Skip to main content

Find Clinical Trials

Home
Conditions
Vulvovaginal Atrophy

Clinical trial condition

Vulvovaginal Atrophy

Explore clinical trials studying Vulvovaginal Atrophy. Study availability and eligibility vary by location and protocol.

41 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Vulvovaginal Atrophy trial results

Recruiting

Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors

NCT07563621

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Jessa Hospital Hasselt, Limburg, Belgium

View Trial Details

Recruiting

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

NCT06900374

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Centre Oscar Lambret Lille, France

View Trial Details

Completed

Psychometric Validation of the Portuguese DIVAS-Q in Women With Vulvovaginal Atrophic Symptoms

NCT07250490

Conditions: Dyspareunia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Personalized Health Care Unit of Sete Rios Lisbon, Lisbon District, Portugal

View Trial Details

Completed

Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM

NCT04746456

Conditions: Genitourinary Syndrome of Menopause, Menopause, Vulvovaginal Atrophy
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness

NCT06846216

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations: Center for Pelvic Health and Wellness Mission Viejo, California, United States

Kimberly L. Evans MD, PLLC Sugar Land, Texas, United States

View Trial Details

Completed

Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

NCT05586711

Conditions: Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women

NCT05367973

Conditions: Vasomotor Symptoms, Vulvovaginal Atrophy
Locations: PARC Clinical Research Adelaide, Southern Australia, Australia

Keogh Institute for Medical Research Nedlands, Western Australia, Australia

View Trial Details

Completed

A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

NCT05418426

Conditions: Vasomotor Symptoms, Vulvovaginal Atrophy
Locations: PARC Clinical Research Melbourne, Australia

Keogh Institute for medical Research Nedlands, Australia

View Trial Details

Completed

A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.

NCT06144814

Conditions: Vulvovaginal Atrophy
Locations: Turkey Ankara, Çankaya, Turkey (Türkiye)

View Trial Details

Completed

Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity

NCT03536585

Conditions: Menopause, Menopause Surgical, Vulvovaginal Atrophy
Locations: Southern Health Centre White Rock, British Columbia, Canada

Dr. George Arnold Markham, Ontario, Canada

Pearl MD Rejuvenation Toronto, Ontario, Canada

View Trial Details